Suxamethonium chloride:
Injection (solution for injection) Suxamethonium chloride 50 mg / ml, ampoule 2 ml.
Injection (powder for injection solution) Suxamethonium chloride.
Note: It is recommended to use powder formulation; liquid requires storage in a refrigerator.
Uses: short-term muscular paralysis during intracranial intubation, endoscopy and electrothermal therapy.
Contraindications: inability to maintain an impervious airway; a personal or family history of malignant hyperplasia; neurological diseases involving severe wasting of a large muscle, prolonged immobility (hyperkalemia risk); personal or family history of congenital muscular dystrophy Glaucoma, eye surgery; liver disease; burns; reduced plasma cholinesterase activity (including severe liver disease); hypercalcemia.
(For long periods of time) with repeated injections (preferably infusion for long surgical procedures); Hepatic impairment; renal impairment; pregnancy;
Dosage:
Muscle relaxation, by intramuscular injection, infant up to 4-5 mg per kg; child up to 4 mg / kg; max 150 mg
Muscle relaxation, intravenous injection, ADULT and CHILD 1 mg / kg followed by necessary supplemental doses 0.5-1 mg / kg at intervals of 5-10 minutes; infant 2 mg / kg
Muscle relaxation (long-term procedures), intravenous infusion, adult 2.5-4 mg per minute with a solution containing 1-2 mg / ml; max 500 mg / h; child reduced infusion rate according to body weight
Adverse effects: postoperative muscle pain, especially in postoperative patients, more common in females; myoglobinemia; myoglobin presence in the blood; long-term respiratory distress; high intraocular pressure; hypercalcemia; low heart rate; Hyperthyroidism, hyperthyroidism, bronchospasm, shock (more common in women, and in hyperthyroidism); History of asthma or asthma); rarely hypothermia Beth (mostly fatal).
Injection (solution for injection) Suxamethonium chloride 50 mg / ml, ampoule 2 ml.
Injection (powder for injection solution) Suxamethonium chloride.
Note: It is recommended to use powder formulation; liquid requires storage in a refrigerator.
Uses: short-term muscular paralysis during intracranial intubation, endoscopy and electrothermal therapy.
Contraindications: inability to maintain an impervious airway; a personal or family history of malignant hyperplasia; neurological diseases involving severe wasting of a large muscle, prolonged immobility (hyperkalemia risk); personal or family history of congenital muscular dystrophy Glaucoma, eye surgery; liver disease; burns; reduced plasma cholinesterase activity (including severe liver disease); hypercalcemia.
(For long periods of time) with repeated injections (preferably infusion for long surgical procedures); Hepatic impairment; renal impairment; pregnancy;
Dosage:
Muscle relaxation, by intramuscular injection, infant up to 4-5 mg per kg; child up to 4 mg / kg; max 150 mg
Muscle relaxation, intravenous injection, ADULT and CHILD 1 mg / kg followed by necessary supplemental doses 0.5-1 mg / kg at intervals of 5-10 minutes; infant 2 mg / kg
Muscle relaxation (long-term procedures), intravenous infusion, adult 2.5-4 mg per minute with a solution containing 1-2 mg / ml; max 500 mg / h; child reduced infusion rate according to body weight
Adverse effects: postoperative muscle pain, especially in postoperative patients, more common in females; myoglobinemia; myoglobin presence in the blood; long-term respiratory distress; high intraocular pressure; hypercalcemia; low heart rate; Hyperthyroidism, hyperthyroidism, bronchospasm, shock (more common in women, and in hyperthyroidism); History of asthma or asthma); rarely hypothermia Beth (mostly fatal).
